AAOMS Annual Meeting

The FDA granted accelerated approval for a new treatment for patients with locally advanced or metastatic urothelial carcinoma.

The FDA granted accelerated approval for a new treatment for patients with locally advanced or metastatic urothelial carcinoma.

Due to manufacturing problems in late 2015, supplies of the US-licensed yellow fever vaccine are expected to be completely depleted by the middle of 2017. In a recent report, the CDC detailed its plan to...

Due to manufacturing problems in late 2015, supplies of the US-licensed yellow fever vaccine are expected to be completely depleted by the middle of 2017. In a recent report, the CDC detailed its plan to...

Due to manufacturing problems in late 2015, supplies of the US-licensed yellow fever vaccine are expected to be completely depleted by the middle of 2017. In a recent report, the CDC detailed its plan to...

The US Food and Drug Administration has approved a new treatment for osteoporosis for postmenopausal women at a high risk for fracture.

The US Food and Drug Administration has approved a new treatment for osteoporosis for postmenopausal women at a high risk for fracture.

The US Food and Drug Administration has approved a new treatment for osteoporosis for postmenopausal women at a high risk for fracture.

The FDA has approved a new drug for the treatment of patients with metastatic anaplastic lymphoma kinase-positive non-small cell lung cancer.

The FDA has approved a new drug for the treatment of patients with metastatic anaplastic lymphoma kinase-positive non-small cell lung cancer.